CACNA1D, calcium voltage-gated channel subunit alpha1 D, 776
N. diseases: 116; N. variants: 35
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Chemically-Induced Disorders; Mental Disorders | Mental or Behavioral Dysfunction | 199 | 39 | 0.020 | None | 1.000 | 2 | 2017 | 2017 | |||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 1112 | 395 | 0.020 | None | 1.000 | 2 | 2015 | 2017 | |||||
|
disease | Nervous System Diseases | Disease or Syndrome | 1215 | 339 | 0.020 | None | 1.000 | 2 | 2016 | 2017 | |||||
|
disease | Nutritional and Metabolic Diseases; Endocrine System Diseases | Disease or Syndrome | 3134 | 2672 | 0.030 | None | 1.000 | 3 | 3 | 1995 | 2013 | ||||
|
disease | Endocrine System Diseases | Disease or Syndrome | 15 | 0.030 | None | 1.000 | 3 | 2015 | 2019 | ||||||
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.040 | None | 1.000 | 4 | 2015 | 2017 | |||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 1071 | 331 | 0.050 | None | 1.000 | 5 | 1 | 2015 | 2018 | ||||
|
disease | Neoplasms; Endocrine System Diseases | Neoplastic Process | 107 | 5 | 0.080 | None | 1.000 | 8 | 2015 | 2016 | |||||
|
group | Nervous System Diseases | Disease or Syndrome | 362 | 247 | 0.100 | None | 1.000 | 9 | 1 | 2000 | 2017 | ||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 6 | 6 | 2015 | 2019 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 5 | 6 | 2015 | 2019 | |||||
|
phenotype | Clinical Attribute | 1014 | 2689 | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | |||||
|
phenotype | Finding | 146 | 344 | 0.100 | None | 1.000 | 2 | 4 | 2018 | 2018 | |||||
|
phenotype | Finding | 80 | 134 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Finding | 57 | 138 | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||
|
phenotype | Mental Process | 854 | 2127 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Behavior and Behavior Mechanisms | Individual Behavior | 391 | 765 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 1756 | 711 | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||
|
phenotype | Clinical Attribute | 36 | 103 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||
|
group | Eye Diseases | Disease or Syndrome | 71 | 75 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||
|
phenotype | Behavior and Behavior Mechanisms | Mental Process | 645 | 2093 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
phenotype | Organism Attribute | 1903 | 3972 | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | |||||
|
disease | Nervous System Diseases; Mental Disorders | Disease or Syndrome | 15 | 26 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
disease | Anatomical Abnormality | 28 | 31 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||
|
disease | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | Disease or Syndrome | 41 | 10 | 0.100 | None | 0 |